Bioequivalence of Two Tablet Forms of MK0974 (0974-045)

NCT00965887 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: MK0974 Ethanolate formulation
DRUG: Comparator: MK0974 Hydrate formulation

Sponsor

Merck Sharp & Dohme LLC